CA2259353C - Emplatre pour l'utilisation transdermique de pergolide - Google Patents

Emplatre pour l'utilisation transdermique de pergolide Download PDF

Info

Publication number
CA2259353C
CA2259353C CA002259353A CA2259353A CA2259353C CA 2259353 C CA2259353 C CA 2259353C CA 002259353 A CA002259353 A CA 002259353A CA 2259353 A CA2259353 A CA 2259353A CA 2259353 C CA2259353 C CA 2259353C
Authority
CA
Canada
Prior art keywords
transdermal therapeutic
therapeutic system
pergolid
group
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002259353A
Other languages
English (en)
Other versions
CA2259353A1 (fr
Inventor
Wilfried Fischer
Anna Sendl-Lang
Dagmar Zeh-Herwerth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19626621A external-priority patent/DE19626621A1/de
Application filed by Hexal AG filed Critical Hexal AG
Publication of CA2259353A1 publication Critical patent/CA2259353A1/fr
Application granted granted Critical
Publication of CA2259353C publication Critical patent/CA2259353C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un emplâtre pour l'utilisation transdermique de pergolide et de ses sels pharmaceutiquement acceptables.
CA002259353A 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide Expired - Fee Related CA2259353C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19626621.1 1996-07-02
DE19626621A DE19626621A1 (de) 1996-07-02 1996-07-02 Pflaster zur transdermalen Anwendung von Pergolid
PCT/EP1997/003458 WO1998000142A1 (fr) 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide

Publications (2)

Publication Number Publication Date
CA2259353A1 CA2259353A1 (fr) 1998-01-08
CA2259353C true CA2259353C (fr) 2006-09-05

Family

ID=36968407

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259353A Expired - Fee Related CA2259353C (fr) 1996-07-02 1997-07-02 Emplatre pour l'utilisation transdermique de pergolide

Country Status (1)

Country Link
CA (1) CA2259353C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821788C1 (de) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Pergolid enthaltend

Also Published As

Publication number Publication date
CA2259353A1 (fr) 1998-01-08

Similar Documents

Publication Publication Date Title
CA2064765C (fr) Appareil pour administration transdermique biphasique de medicaments
CA1261267A (fr) Administration transdermique du timolol
CA2653827C (fr) Preparation innovante de blonanserin en ruban
US6783769B1 (en) Transdermal therapeutic system TTS containing tolterodine
CA2550704C (fr) Dispositif d'administration transdermique de nicotine
KR20010036685A (ko) 펜타닐을 함유하는 매트릭스형 경피투여제
US5399355A (en) Agent for transdermal administration containing ergoline derivatives
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
NZ306429A (en) transdermal system containing a matrix of polyisobutane or butyl rubber and an angiotensin converting enzyme inhibitor
US20040253299A1 (en) Transdermal therapeutic system (reservoir-tts) for using pramipexole and ropinirole
US8226974B2 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
US6335030B1 (en) Transdermally administered dextromethorphan as antitussive agent
US6558696B1 (en) Desoxypeganine
US6623752B1 (en) Patch for transdermal application for pergolid
US20070202156A1 (en) Adhesive preparation comprising sufentanil and methods of using same
JP2000514053A (ja) ペルゴリドの経皮投与用硬膏
EP1711170B1 (fr) Dispositif d'administration transdermique d'antagonistes calciques de type dihydropyridine renfermant deux acides gras
CA2259353C (fr) Emplatre pour l'utilisation transdermique de pergolide
US10420733B2 (en) Transdermal delivery system containing methylphenidate or its salts and methods thereof
WO1997006788A1 (fr) Administration trans-cutanee de vorozole
EP0879051A1 (fr) Administration transdermique a vitesse de diffusion regulee de risperidone
US20040081682A1 (en) Transdermal system (tds) that contain inhibitors of phosphodiesterase lV
US20030175330A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
AU696789C (en) Rate-controlled transdermal administration of risperidone

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed